Clinical trials
Phase 4 Heart Arrest trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 7 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hospital San Carlos, Madrid | 2 |
| Lars Wiuff Andersen | 2 |
| Rigshospitalet, Denmark | 2 |
| Singapore General Hospital | 2 |
| Tang Ziren | 2 |
| University of Washington | 2 |
| Bo Gregers Winkel | 1 |
| Boston Scientific Corporation | 1 |
| Far Eastern Memorial Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Arrest | 34 |
| Hypothermia | 7 |
| Out-of-Hospital Cardiac Arrest | 5 |
| Coma | 2 |
| Death, Sudden, Cardiac | 2 |
| Emergencies | 2 |
| Hemorrhagic Stroke | 2 |
| Shock | 2 |
| Tachycardia, Ventricular | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.